Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: SickKids-CIHR-IHDCYH New Investigator Grants

University of Toronto

$297,594.00

Prediction of Intraventricular Hemmorhage using Echocardiography and Near Infrared Spectroscopy (PIE-NIRS)

FY 2022-23

Summary
Background:¿ Moderate to severe intraventricular hemorrhage (msIVH; Grades II-IV) affects ~25-30% of Canadian extremely-low-gestational-age-neonates (ELGANs; <27+6 weeks) and leads to long-term neurodisability. A targeted preventative approach is challenged by our inability to identify at-risk ELGANs early. Pilot studies using Near-infrared spectroscopy (NIRS), including our own, found lower cerebral saturations (CrSO2) and greater periods of altered cerebral autoregulation in infants who subsequently developed msIVH. However, the predictive characteristics of NIRS-derived markers using clinically translatable methods need to be established. Further, incorporating relevant echocardiographic (ECHO) markers may improve prediction models and provide mechanistic hemodynamic insights to inform future management. Objective: To investigate the utility of multi-modal assessment using NIRS and ECHO for early identification of ELGANs at risk of msIVH. Specific aims: 1. To examine individual and combined discriminating characteristics of NIRS-derived parameters (CrSO2 [cumulative % time spent below thresholds of <55%, <60%, <65% and <70%] and cerebral oxygenation index [COIx, values >0.5 = altered autoregulation]) at 12, 18, 24, 30, 36, 42 and 48 hours of age, for msIVH. 2. To examine added value of ECHO parameters (left ventricular output, superior vena cava flow, patent ductus arteriosus size) and patient demographics in improving discriminating characteristics of NIRS. Design:¿Prospective observational cohort study conducted over three years at three Canadian tertiary NICUs. Inclusion criteria: GA at birth = 27+6. Exclusion criteria: Genetic or congenital anomalies. Intervention:¿Following informed parental consent, obtained <12 hours of birth, ELGANs will undergo: •Cerebral NIRS monitoring (CrSO2 and COIx) until 48 hours of age. •2 ECHOs: 1st < 24 hours, 2nd 48-60 hours of age. •2 head ultrasounds: 1st <24 hours, 2nd day 4-7 of age. Outcome of interest:¿msIVH on 2nd head ultrasound. Sample size: 345 infants (expecting 28% prevalence of¿msIVH based on pilot data, and Area under Curve of 0.86, precision of 0.05 and 10% data loss)
Program
Operating Grant: SickKids-CIHR-IHDCYH New Investigator Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
471423
Name
Deshpande Poorva
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
Prediction of Intraventricular Hemmorhage using Echocardiography and Near Infrared Spectroscopy (PIE-NIRS)
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$297,594
Cihrequipment2
$0
Programname2
Operating Grant: SickKids-CIHR-IHDCYH New Investigator Grants
Keyworddelim
.
Abstract
Background:¿ Moderate to severe intraventricular hemorrhage (msIVH; Grades II-IV) affects ~25-30% of Canadian extremely-low-gestational-age-neonates (ELGANs; <27+6 weeks) and leads to long-term neurodisability. A targeted preventative approach is challenged by our inability to identify at-risk ELGANs early. Pilot studies using Near-infrared spectroscopy (NIRS), including our own, found lower cerebral saturations (CrSO2) and greater periods of altered cerebral autoregulation in infants who subsequently developed msIVH. However, the predictive characteristics of NIRS-derived markers using clinically translatable methods need to be established. Further, incorporating relevant echocardiographic (ECHO) markers may improve prediction models and provide mechanistic hemodynamic insights to inform future management. Objective: To investigate the utility of multi-modal assessment using NIRS and ECHO for early identification of ELGANs at risk of msIVH. Specific aims: 1. To examine individual and combined discriminating characteristics of NIRS-derived parameters (CrSO2 [cumulative % time spent below thresholds of <55%, <60%, <65% and <70%] and cerebral oxygenation index [COIx, values >0.5 = altered autoregulation]) at 12, 18, 24, 30, 36, 42 and 48 hours of age, for msIVH. 2. To examine added value of ECHO parameters (left ventricular output, superior vena cava flow, patent ductus arteriosus size) and patient demographics in improving discriminating characteristics of NIRS. Design:¿Prospective observational cohort study conducted over three years at three Canadian tertiary NICUs. Inclusion criteria: GA at birth = 27+6. Exclusion criteria: Genetic or congenital anomalies. Intervention:¿Following informed parental consent, obtained <12 hours of birth, ELGANs will undergo: •Cerebral NIRS monitoring (CrSO2 and COIx) until 48 hours of age. •2 ECHOs: 1st < 24 hours, 2nd 48-60 hours of age. •2 head ultrasounds: 1st <24 hours, 2nd day 4-7 of age. Outcome of interest:¿msIVH on 2nd head ultrasound. Sample size: 345 infants (expecting 28% prevalence of¿msIVH based on pilot data, and Area under Curve of 0.86, precision of 0.05 and 10% data loss)
Competitiondate
202204
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Deshpande, Poorva
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Human Dev &amp;Child &amp;Yth~ $297,594~ $0~
University of Toronto - $297,594 Grant (2022-23) | Canada Spends